0000000000616580
AUTHOR
Domenico Campisi
showing 14 related works from this author
Effetto di due vini rossi siciliani su alcuni fattori di rischio cardiovascolare
2004
Background. The aim of this study was to evaluate whether Sicilian red wine consumption is associated with a lower cardiovascular risk. Methods. Forty-eight subjects of both sexes (age range 35-65 years) nondrinkers or rarely drinkers of moderate red wine intake were selected. Subjects were divided into two groups (group A and group B), assigned to receive with a crossover design 250 ml/die (during the meals) of one of two types of Sicilian red wines (Nero d’Avola and Etna Torrepalino respectively). At all visits (-15 days, basal, +4 and +8 weeks) the following parameters were measured: blood glucose, total cholesterol and triglycerides (by enzyme kit methods, Boehringer Mannheim, Milan, It…
The profession of doctor in Sicily
2007
Indium-111 Oxine Platelets Survival In Patients Suffering Of Cardiac And Cerebral Arteriosclerosis
2006
Salvaguardia e valorizzazione di razze ovine autoctone siciliane
2006
Antica saggezza contadina e realtà moderna: il vino rosso ed i suoi benefici effetti sulla salute
2006
Relationship between body fat distribution and blood disorders in patients with visceral obesity with and without diabetes mellitus
2008
Sicilian red wines and cardiovascular risk factors: short term and cross over study
2004
Effects of moderate consumption of sicilian red wines on some cardiovascular risk factors
2006
Effetti a lungo termine del trattamento con Simvastatina ed Ezetimibe sui livelli di HDL-C e hs-PCR in pazienti affetti da Ipercolesterolemia familar…
2008
Efficacia della Atorvastatina E n-3 Pufa in pazienti affetti da dislipidemia combinata e ad alto rischio di eventi cardiovascolari
2008
Efficacia della associazione Atorvastatina e n-3 PUFA in pazienti affetti da dislipidemia combinata e ad alto rischio di eventi cardiovascolari
2008
One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease.
2006
Aim. Statins are the drugs of choice in heterozygous familial hypercholesterolemia (FH), which has a high risk of premature cardiovascular events including myocardial infarction, stroke, and surgical revascularization. Methods. A 1-year open-label study was conducted to test the efficacy and tolerability of Atorvastatin titrated to the target, in proven FH patients and to evaluate certain inflammatory parameters. One hundred and two FH patients (44 men and 58 women; mean age 58.7±3.6 years) were included in the study. After evaluation using the B-mode duplex scanning system of extracranial carotid arteries, the patients were divided into groups: Group 1 (15 men, 25 women) with carotid plaqu…